Whiterabbit

Whiterabbit.ai is an AI technology company with the mission to improve lives through earlier and more accurate cancer detection. An increasing number of radiologists and healthcare providers are utilizing Whiterabbit's technology to enhance the breast cancer screening experience for patients. In addition to ACT, Whiterabbit has developed two other product lines—WRDensity and WRRisk. WRDensity is an FDA-approved, AI-driven software that assists radiologists in better assessing breast density. WRRisk is a clinical decision support software that evaluates risk based on established breast cancer risk models. It assigns a risk rating to patients and provides critical information to physicians, enabling them to create more personalized screening plans, ensure consistent follow-ups, and achieve more accurate clinical diagnoses.